| __timestamp | Insmed Incorporated | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 33534999 | 60987000 |
| Thursday, January 1, 2015 | 1982000 | 125542000 |
| Friday, January 1, 2016 | 2438000 | 210460000 |
| Sunday, January 1, 2017 | 2901000 | 275119000 |
| Monday, January 1, 2018 | 2423000 | 409539000 |
| Tuesday, January 1, 2019 | 24212000 | 547758000 |
| Wednesday, January 1, 2020 | 39872000 | 736300000 |
| Friday, January 1, 2021 | 44152000 | 904200000 |
| Saturday, January 1, 2022 | 55126000 | 1080300000 |
| Sunday, January 1, 2023 | 65573000 | 1262200000 |
| Monday, January 1, 2024 | 1530500000 |
Unveiling the hidden dimensions of data
In the ever-evolving world of biotechnology, understanding cost dynamics is crucial. Vertex Pharmaceuticals Incorporated and Insmed Incorporated, two prominent players, have shown distinct trends in their cost of revenue over the past decade. From 2014 to 2023, Vertex Pharmaceuticals has seen a staggering increase of over 1,900% in its cost of revenue, reflecting its aggressive expansion and investment in cutting-edge therapies. In contrast, Insmed Incorporated, while smaller in scale, has experienced a more modest growth of approximately 95% during the same period.
Vertex's cost of revenue surged from around $61 million in 2014 to over $1.26 billion in 2023, highlighting its commitment to innovation and market leadership. Meanwhile, Insmed's cost of revenue rose from about $33 million to $66 million, indicating steady growth and strategic investments. These trends underscore the diverse strategies employed by biotech firms to navigate the competitive landscape.
Comparing Cost of Revenue Efficiency: Pfizer Inc. vs Insmed Incorporated
Gilead Sciences, Inc. vs Insmed Incorporated: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Vertex Pharmaceuticals Incorporated vs Dr. Reddy's Laboratories Limited
Cost Insights: Breaking Down Vertex Pharmaceuticals Incorporated and Alkermes plc's Expenses
Cost of Revenue Comparison: Vertex Pharmaceuticals Incorporated vs Supernus Pharmaceuticals, Inc.
Vertex Pharmaceuticals Incorporated vs Wave Life Sciences Ltd.: Efficiency in Cost of Revenue Explored
Takeda Pharmaceutical Company Limited vs Insmed Incorporated: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Insmed Incorporated and Catalent, Inc.'s Expenses
Insmed Incorporated vs Sarepta Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Insmed Incorporated vs Jazz Pharmaceuticals plc
Cost of Revenue Comparison: Insmed Incorporated vs Xenon Pharmaceuticals Inc.
Analyzing Cost of Revenue: Insmed Incorporated and Xencor, Inc.